Obesity
📧 Sign up to get email alerts when something new happens for Obesity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS guidance · 2026-04-13Clinical Trial Update: iAmHealthy Clinical Practice Guideline (CPG) [NA]
A clinical practice guideline update under the iAmHealthy program is currently recruiting participants, focusing on pediatric obesity and ru…
-
EMA guidance · 2025-10-21EMA partners with content creators to promote safe and responsible use of GLP-1 medicines
EMA partners with content creators to promote safe and responsible use of GLP-1 medicines through the HealthNotHype campaign, expanding reac…
-
EMA guidance · 2024-11-15Updated advice to minimise risks of interaction between weight loss medicine Mysimba and opioids
EMA updated guidance to minimize the risk of serious interactions between Mysimba (naltrexone/bupropion) and opioid medicines. The agency no…
-
EMA guidance · 2024-06-26EU actions to tackle shortages of GLP-1 receptor agonists
EMA outlines recommendations from the Multi-Stakeholder Supply Group (MSSG) and actions to address shortages of GLP-1 receptor agonists in t…
-
CLINICAL_TRIALS guidance · 2014-10-23Clinical Trial Update: Guidance in Diet and Physical Activity for Prevention of Weight Gain After Gastric Bypass Surgery [NA]
This clinical trial update outlines recommendations on diet and physical activity to prevent weight regain after gastric bypass surgery.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.